Synergy Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 78   

Articles published

SGYP 2.66 -0.12 (-4.49%)
price chart
Synergy Pharmaceuticals Could Be A Diamond In The Rough
It seems to me that the market currently values Synergy as though it will be forced to market plecanatide on its own (an expensive proposition), but I believe some sort of partnering arrangement, if not an outright sale of the company, is more likely ...
Synergy Pharmaceuticals Inc (SGYP) Jumps 5.34% on September 26
Synergy Pharmaceuticals Inc (SGYP) was among the biggest gainers on the Russell 2000 for September 26 as the stock popped 5.34% to $2.96, representing a gain of $0.15 per share.
Related articles »  
Synergy Pharma Reaches Halfway Mark For Second Phase 3 Trial Of Plecanatide
(RTTNews.com) - Synergy Pharmaceuticals Inc. ( SGYP ) announced that it has reached the halfway mark for total enrollment in the second pivotal phase 3 trial of plecanatide in patients with chronic idiopathic constipation or CIC.
Synergy Pharmaceuticals Reaches Halfway Mark for Second Pivotal Phase 3 ...  MarketWatch
Related articles »  
Synergy Pharmaceuticals Coverage Initiated at Cowen and Company (SGYP)
Synergy Pharmaceuticals Inc logo Cowen and Company began coverage on shares of Synergy Pharmaceuticals (NASDAQ:SGYP) in a report released on Friday.
Related articles »  
Intraday Movers:Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Unilever N.V. ...
Manhattan, NY- SEP 26, 2014 - (Techsonian) �Synergy Pharmaceuticals Inc (NASDAQ:SGYP)declared that it has reached the halfway mark for total enrollment in the second pivotal phase 3 trial of plecanatide in patients with chronic idiopathic constipation ...
Synergy Pharmaceuticals Reaches New 1-Year Low at $2.84 (SGYP)  Intercooler
Related articles »  
Synergy Pharmaceuticals Now Covered by Analysts at Cowen and Company ...
Synergy Pharmaceuticals Inc logo Cowen and Company started coverage on shares of Synergy Pharmaceuticals (NASDAQ:SGYP) in a research note released on Friday morning.
Slumping Stocks: Synergy Pharmaceuticals Inc(NASDAQ:SGYP), Aeropostale ...  NIS
Related articles »  
Stocks Alert �Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Cloud Peak ...
New York, NY- September 23, 2014 - (TechSonian) �OTC PENNY ALERTShas a finger on the pulse of many sectors including renewable energy, oil, pharmaceuticals, mining, finance, technology and healthcare. Whenever a breakout micro-cap or ...
Related articles »  
Active Stocks: Synergy Pharmaceuticals Inc. (NASDAQ:SGYP), SinoCoking Coal ...
Dallas, Texas, 09/19/2014 (ustrademedia) - Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) announced to reach the halfway mark for total patient enrollment in second Phase III trial of plecanatide, aimed at studying the efficacy and safety of once-daily ...
Stocks Intraday Alert - Synergy Pharmaceuticals Inc (SGYP), Dynavax ...
Las Vegas, NV - 19 SEP, 2014 - (TechSonian) �Synergy Pharmaceuticals Inc (NASDAQ:SGYP) revealed that it has reached the halfway mark for total enrollment in the second pivotal phase 3 trial of plecanatide in patients with chronic idiopathic ...
Hot Stock's Alert - CalAmp Corp. (NASDAQ:CAMP), Synergy Pharmaceuticals ...
Birmingham, West Midlands - (TechSonian) - 01 OCT 2014 - CalAmp Corp. (NASDAQ:CAMP) a leading provider of wireless products, services and solutions, recently declared that it will release its operating results for its fiscal 2015 second quarter ...